These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10626673)

  • 1. CCR5 delta32, matrix metalloproteinase-9 and disease activity in multiple sclerosis.
    Sellebjerg F; Madsen HO; Jensen CV; Jensen J; Garred P
    J Neuroimmunol; 2000 Jan; 102(1):98-106. PubMed ID: 10626673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokines and matrix metalloproteinase-9 in leukocyte recruitment to the central nervous system.
    Sellebjerg F; Sørensen TL
    Brain Res Bull; 2003 Aug; 61(3):347-55. PubMed ID: 12909304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCR5Delta32 polymorphism effects on CCR5 expression, patterns of immunopathology and disease course in multiple sclerosis.
    Kantarci OH; Morales Y; Ziemer PA; Hebrink DD; Mahad DJ; Atkinson EJ; Achenbach SJ; De Andrade M; Mack M; Ransohoff RM; Lassmann H; Bruck W; Weinshenker BG; Lucchinetti CF
    J Neuroimmunol; 2005 Dec; 169(1-2):137-43. PubMed ID: 16182378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCR5-Delta32 genetic polymorphism associated with benign clinical course and magnetic resonance imaging findings in Brazilian patients with multiple sclerosis.
    Kaimen-Maciel DR; Reiche EM; Brum Souza DG; Frota Comini ER; Bobroff F; Morimoto HK; Ehara Watanabe MA; Carvalho De Oliveira J; Matsuo T; Lopes J; Donadi EA
    Int J Mol Med; 2007 Sep; 20(3):337-44. PubMed ID: 17671738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The chemokine receptor CCR5 Δ32 allele in natalizumab-treated multiple sclerosis.
    Møller M; Søndergaard HB; Koch-Henriksen N; Sorensen PS; Sellebjerg F; Oturai AB
    Acta Neurol Scand; 2014 Jan; 129(1):27-31. PubMed ID: 23668375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokine receptor V Δ32 deletion in multiple sclerosis patients in Csongrád County in Hungary and the North-Bácska region in Serbia.
    Török N; Molnár K; Füvesi J; Karácsony M; Zsiros V; Fejes-Szabó A; Fiatal S; Ádány R; Somogyvári F; Stojiljković O; Vécsei L; Bencsik K
    Hum Immunol; 2015 Jan; 76(1):59-64. PubMed ID: 25500253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Meta-analysis of the relation between chemokine receptor 5 delta32 polymorphism and multiple sclerosis susceptibility.
    Song GG; Lee YH
    Immunol Invest; 2014; 43(4):299-311. PubMed ID: 24295368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in CCR5 Delta32/Delta32 genotype in multiple sclerosis.
    Pulkkinen K; Luomala M; Kuusisto H; Lehtimäki T; Saarela M; Jalonen TO; Elovaara I
    Acta Neurol Scand; 2004 May; 109(5):342-7. PubMed ID: 15080861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the beta-chemokine receptors CCR2, CCR3 and CCR5 in multiple sclerosis central nervous system tissue.
    Simpson J; Rezaie P; Newcombe J; Cuzner ML; Male D; Woodroofe MN
    J Neuroimmunol; 2000 Aug; 108(1-2):192-200. PubMed ID: 10900353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of CCR5 delta32 deletion with early death in multiple sclerosis.
    Gade-Andavolu R; Comings DE; MacMurray J; Rostamkhani M; Cheng LS; Tourtellotte WW; Cone LA
    Genet Med; 2004; 6(3):126-31. PubMed ID: 15354329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential intracellular expression of CCR5 and chemokines in multiple sclerosis subtypes.
    Jalonen TO; Pulkkinen K; Ukkonen M; Saarela M; Elovaara I
    J Neurol; 2002 May; 249(5):576-83. PubMed ID: 12021948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cells in the cerebrospinal fluid express a similar repertoire of inflammatory chemokine receptors in the absence or presence of CNS inflammation: implications for CNS trafficking.
    Kivisäkk P; Trebst C; Liu Z; Tucky BH; Sørensen TL; Rudick RA; Mack M; Ransohoff RM
    Clin Exp Immunol; 2002 Sep; 129(3):510-8. PubMed ID: 12197893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 Infection in Persons Homozygous for CCR5-Δ32 Allele: The Next Case and the Review.
    Smoleń-Dzirba J; Rosińska M; Janiec J; Beniowski M; Cycoń M; Bratosiewicz-Wąsik J; Wąsik TJ
    AIDS Rev; 2017 Dec; 19(4):219-230. PubMed ID: 28534889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune response genes receptors expression and polymorphisms in relation to multiple sclerosis susceptibility and response to INF-β therapy.
    Karam RA; Rezk NA; Amer MM; Fathy HA
    IUBMB Life; 2016 Sep; 68(9):727-34. PubMed ID: 27346865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCL5 and CCR5 genotypes modify clinical, radiological and pathological features of multiple sclerosis.
    van Veen T; Nielsen J; Berkhof J; Barkhof F; Kamphorst W; Bö L; Ravid R; Verweij CL; Huitinga I; Polman CH; Uitdehaag BM
    J Neuroimmunol; 2007 Oct; 190(1-2):157-64. PubMed ID: 17884183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the CC chemokine receptor 5 delta32 polymorphism in a Brazilian population with cutaneous leishmaniasis.
    Brajão de Oliveira K; Reiche EM; Kaminami Morimoto H; Pelegrinelli Fungaro MH; Estevão D; Pontello R; Franco Nasser T; Watanabe MA
    J Cutan Pathol; 2007 Jan; 34(1):27-32. PubMed ID: 17214851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCR2(+)CCR5(+) T cells produce matrix metalloproteinase-9 and osteopontin in the pathogenesis of multiple sclerosis.
    Sato W; Tomita A; Ichikawa D; Lin Y; Kishida H; Miyake S; Ogawa M; Okamoto T; Murata M; Kuroiwa Y; Aranami T; Yamamura T
    J Immunol; 2012 Nov; 189(10):5057-65. PubMed ID: 23071279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CC chemokine receptor 5 delta32 polymorphism in two independent cohorts of hepatitis C virus infected patients without hemophilia.
    Wasmuth HE; Werth A; Mueller T; Berg T; Dietrich CG; Geier A; Schirin-Sokhan R; Gartung C; Lorenzen J; Matern S; Lammert F
    J Mol Med (Berl); 2004 Jan; 82(1):64-9. PubMed ID: 14673528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE.
    Eltayeb S; Berg AL; Lassmann H; Wallström E; Nilsson M; Olsson T; Ericsson-Dahlstrand A; Sunnemark D
    J Neuroinflammation; 2007 May; 4():14. PubMed ID: 17484785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional Promoter Polymorphisms of MMP-2 C-735T and MMP-9 C-1562T and Their Synergism with MMP-7 A-181G in Multiple Sclerosis.
    Rahimi Z; Abdan Z; Rahimi Z; Razazian N; Shiri H; Vaisi-Raygani A; Shakiba E; Vessal M; Moradi MT
    Immunol Invest; 2016 Aug; 45(6):543-52. PubMed ID: 27409770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.